MOLN MONDAY DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action – MOLN
September 10, 2022 12:18 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 10, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or...
Investors who Lost over $100,000 in Molecular Partners AG (NASDAQ: MOLN) shares should contact the Shareholders Foundation in connection with pending Lawsuit
August 29, 2022 07:05 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Molecular Partners AG (NASDAQ: MOLN) shares. Investors...
MOLN NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action – MOLN
August 26, 2022 19:45 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 26, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Molecular Partners AG Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – MOLN
August 20, 2022 12:14 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 20, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or...
MOLN LOSS ALERT: GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Molecular Partners AG Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MOLN
August 09, 2022 16:15 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or...
ROSEN, A TOP RANKED FIRM, Encourages Molecular Partners AG Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – MOLN
July 31, 2022 14:44 ET
|
The Rosen Law Firm PA
NEW YORK, July 31, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or...
ROSEN, A LEADING LAW FIRM, Encourages Molecular Partners AG Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – MOLN
July 27, 2022 17:44 ET
|
The Rosen Law Firm PA
NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or...
Molecular Partners AG Shareholder Update: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Molecular Partners AG (MOLN)
July 22, 2022 19:38 ET
|
Robbins LLP
SAN DIEGO, July 22, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons who purchased or...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action – MOLN
July 20, 2022 14:00 ET
|
The Rosen Law Firm PA
NEW YORK, July 20, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or...
Molecular Partners ADRs Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Molecular Partners AG
April 29, 2022 11:15 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Molecular Partners AG ADRs ("Molecular Partners" or...